{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:03:39Z","timestamp":1782911019491,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T00:00:00Z","timestamp":1350345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11095-012-0888-0","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T17:38:06Z","timestamp":1350495486000},"page":"435-446","source":"Crossref","is-referenced-by-count":67,"title":["Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata"],"prefix":"10.1007","volume":"30","author":[{"given":"Yin-Ku","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Al-Suwayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann-Lii","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"888_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","volume":"149","author":"SP MacDonald Hull","year":"2003","unstructured":"MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guidelines for the management of alopecia areata. Br J Dermatol. 2003;149:692\u20139.","journal-title":"Br J Dermatol"},{"key":"888_CR2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/08923970903440200","volume":"32","author":"H Pazoki-Toroudi","year":"2010","unstructured":"Pazoki-Toroudi H, Ajami M, Babakoohi S, Khaki L, Habibey R, Akhiani M, et al. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata. Immunopharmacol Immunotoxicol. 2010;32:422\u20135.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"888_CR3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-3083.2009.03401.x","volume":"24","author":"BM El-Zawahry","year":"2010","unstructured":"El-Zawahry BM, Bassiouny DA, Khella A, Zaki NS. Five-year experience in the treatment of alopecia areata with DPC. J Eur Acad Dermatol Venereol. 2010;24:264\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"888_CR4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","volume":"22","author":"G Avgerinou","year":"2008","unstructured":"Avgerinou G, Gregoriou S, Rigopoulos D, Stratigos A, Kalogeromitros D, Katsambas A. Alopecia areata: topical immunotherapy treatment with diphencyprone. J Eur Acad Dermatol Venereol. 2008;22:320\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"888_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update. Part II. Treatment. J Am Acad Dermatol. 2010;62:191\u2013202.","journal-title":"J Am Acad Dermatol"},{"key":"888_CR6","doi-asserted-by":"crossref","first-page":"171265","DOI":"10.1155\/2010\/171265","volume":"2010","author":"MC Pires","year":"2010","unstructured":"Pires MC, Martins JM, Montealegre F, Gatti FR. Vitiligo after diphencyprone for alopecia areata. Dermatol Res Pract. 2010;2010:171265.","journal-title":"Dermatol Res Pract"},{"key":"888_CR7","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"888_CR8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","volume":"100","author":"E Gonz\u00e1lez-Mira","year":"2011","unstructured":"Gonz\u00e1lez-Mira E, Nikoli\u0107 S, Garc\u00eda ML, Egea MA, Souto EB, Calpena AC. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci. 2011;100:242\u201351.","journal-title":"J Pharm Sci"},{"key":"888_CR9","first-page":"1063","volume":"137","author":"MC Wiseman","year":"2001","unstructured":"Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol. 2001;137:1063\u20138.","journal-title":"Arch Dermatol"},{"key":"888_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jps.22741","volume":"101","author":"C Puglia","year":"2012","unstructured":"Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, et al. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. J Pharm Sci. 2012;101:301\u201311.","journal-title":"J Pharm Sci"},{"key":"888_CR11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.jid.5700733","volume":"127","author":"B Baroli","year":"2007","unstructured":"Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, L\u00f3pez-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127:1701\u201312.","journal-title":"J Invest Dermatol"},{"key":"888_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000131080","volume":"21","author":"LW Zhang","year":"2008","unstructured":"Zhang LW, Monteiro-Riviere NA. Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol Physiol. 2008;21:166\u201380.","journal-title":"Skin Pharmacol Physiol"},{"key":"888_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0022-202X.2005.23779.x","volume":"125","author":"A Teichmann","year":"2005","unstructured":"Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol. 2005;125:264\u20139.","journal-title":"J Invest Dermatol"},{"key":"888_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5173(01)00824-9","volume":"229","author":"G Betz","year":"2001","unstructured":"Betz G, Imboden R, Imanidis G. Interaction of liposome formulations with human skin in vitro. Int J Pharm. 2001;229:117\u201329.","journal-title":"Int J Pharm"},{"key":"888_CR15","first-page":"1599","volume":"7","author":"CJ Wen","year":"2012","unstructured":"Wen CJ, Zhang LW, Al-Suwayeh SA, Yen TC, Fang JY. Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int J Nanomed. 2012;7:1599\u2013611.","journal-title":"Int J Nanomed"},{"key":"888_CR16","doi-asserted-by":"crossref","first-page":"405101","DOI":"10.1088\/0957-4484\/21\/40\/405101","volume":"21","author":"SH Hsu","year":"2010","unstructured":"Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers (NLCs) for targeting the brain: apomorphine as a model drug. Nanotechnology. 2010;21:405101.","journal-title":"Nanotechnology"},{"key":"888_CR17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2005.09.052","volume":"110","author":"H Chen","year":"2006","unstructured":"Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Contr Rel. 2006;110:296\u2013306.","journal-title":"J Contr Rel"},{"key":"888_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0939-6411(01)00167-9","volume":"52","author":"E Zimmermann","year":"2001","unstructured":"Zimmermann E, M\u00fcller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN\u00ae) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm. 2001;52:203\u201310.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpb.2007.07.006","volume":"68","author":"RH M\u00fcller","year":"2008","unstructured":"M\u00fcller RH, Runge SA, Ravelli V, Th\u00fcnemann AF, Mehnert W, Souto EB. Cyclosporine-loaded solid lipid nanoparticles (SLN\u00ae): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm. 2008;68:535\u201344.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2009.06.008","volume":"38","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Lipid nanoparticles with different oil\/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci. 2009;38:138\u201346.","journal-title":"Eur J Pharm Sci"},{"key":"888_CR21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejps.2005.10.004","volume":"27","author":"MA Schubert","year":"2006","unstructured":"Schubert MA, Harms M, M\u00fcller-Goymann CC. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci. 2006;27:226\u201336.","journal-title":"Eur J Pharm Sci"},{"key":"888_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archderm.138.1.112","volume":"138","author":"R Happle","year":"2002","unstructured":"Happle R. Diphencyprone for the treatment of alopecia areata: more data and new aspects. Arch Dermatol. 2002;138:112\u20133.","journal-title":"Arch Dermatol"},{"key":"888_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/toxsci\/kfp139","volume":"111","author":"NV Gopee","year":"2009","unstructured":"Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Latendresse JR, et al. Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol Sci. 2009;111:37\u201348.","journal-title":"Toxicol Sci"},{"key":"888_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.21817","volume":"99","author":"B Baroli","year":"2010","unstructured":"Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci. 2010;99:21\u201350.","journal-title":"J Pharm Sci"},{"key":"888_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2005.09.045","volume":"110","author":"S Lombardi Borgia","year":"2005","unstructured":"Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, et al. Lipid nanoparticles for skin penetration enhancement\u2013correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Contr Rel. 2005;110:151\u201363.","journal-title":"J Contr Rel"},{"key":"888_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","volume":"59","author":"M Sch\u00e4fer-Korting","year":"2007","unstructured":"Sch\u00e4fer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427\u201343.","journal-title":"Adv Drug Deliv Rev"},{"key":"888_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09687688.2010.522203","volume":"27","author":"P Desai","year":"2010","unstructured":"Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27:247\u201359.","journal-title":"Mol Membr Biol"},{"key":"888_CR28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170\u201384.","journal-title":"Int J Pharm"},{"key":"888_CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3109\/02652040902746679","volume":"26","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers, and solid lipid nanoparticles. J Microencapsul. 2009;26:734\u201347.","journal-title":"J Microencapsul"},{"key":"888_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2011.04.009","volume":"79","author":"MMA Abdel-Mottaleb","year":"2011","unstructured":"Abdel-Mottaleb MMA, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm. 2011;79:36\u201342.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR31","doi-asserted-by":"crossref","first-page":"095103","DOI":"10.1088\/0957-4484\/23\/9\/095103","volume":"23","author":"KS Liu","year":"2012","unstructured":"Liu KS, Wen CJ, Yen TC, Sung KC, Ku MC, Wang JJ, et al. Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers (NLCs) for efficient brain targeting. Nanotechnology. 2012;23:095103.","journal-title":"Nanotechnology"},{"key":"888_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2008.11.001","volume":"71","author":"F Knorr","year":"2009","unstructured":"Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route\u2013research progress and future perspectives. Eur J Pharm Biopharm. 2009;71:173\u201380.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR33","doi-asserted-by":"crossref","first-page":"021001","DOI":"10.1117\/1.3080714","volume":"14","author":"S Jung","year":"2009","unstructured":"Jung S, Patzelt A, Otberg N, Thiede G, Sterry W, Lademann J. Strategy of topical vaccination with nanoparticles. J Biomed Opt. 2009;14:021001.","journal-title":"J Biomed Opt"},{"key":"888_CR34","first-page":"537","volume":"16","author":"AG Messenger","year":"2006","unstructured":"Messenger AG. Alopecia areata. Eur J Dermatol. 2006;16:537\u201342.","journal-title":"Eur J Dermatol"},{"key":"888_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2008.08.019","volume":"71","author":"S K\u00fcchler","year":"2009","unstructured":"K\u00fcchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, et al. Nanoparticles for skin penetration enhancement\u2013a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm. 2009;71:243\u201350.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR36","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","volume":"66","author":"H Hillaireau","year":"2009","unstructured":"Hillaireau H, Couvreur P. Nanocarriers\u2019 entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009;66:2873\u201396.","journal-title":"Cell Mol Life Sci"},{"key":"888_CR37","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1158\/0008-5472.CAN-06-2354","volume":"66","author":"W Lu","year":"2006","unstructured":"Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res. 2006;66:11878\u201387.","journal-title":"Cancer Res"},{"key":"888_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2009.01.014","volume":"372","author":"Q Lv","year":"2009","unstructured":"Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009;372:191\u20138.","journal-title":"Int J Pharm"},{"key":"888_CR39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpb.2004.03.027","volume":"58","author":"R Alvarez-Rom\u00e1n","year":"2004","unstructured":"Alvarez-Rom\u00e1n R, Naik YN, Fessi H, Guy RH. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm. 2004;58:301\u201316.","journal-title":"Eur J Pharm Biopharm"},{"key":"888_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.0022-202X.2003.22110.x","volume":"122","author":"N Otberg","year":"2004","unstructured":"Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122:14\u20139.","journal-title":"J Invest Dermatol"},{"key":"888_CR41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2006.11.014","volume":"30","author":"Y Frum","year":"2007","unstructured":"Frum Y, Bonner MC, Eccleston GM, Meidan VM. The influence of drug partition coefficient on follicular penetration: in vitro human skin studies. Eur J Pharm Sci. 2007;30:280\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"888_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2125.2009.03463.x","volume":"68","author":"S Trauer","year":"2009","unstructured":"Trauer S, Patzelt A, Otberg N, Knorr F, Rozycki C, Balizs G, et al. Permeation of topically applied caffeine through human skin\u2013a comparison of in vivo and in vitro data. Br J Clin Pharmacol. 2009;68:181\u20136.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-012-0888-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0888-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:22:19Z","timestamp":1562268139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-012-0888-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1007\/s11095-012-0888-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}